Insilico Medicine & Takeda Partner: AI‑Powered Drug Discovery Deal Worth Up to $600 Million
Insilico Medicine teams with Takeda to launch a $600 M AI‑driven drug discovery partnership, boosting pipeline speed and market value.
- INSILICO MEDICINE CAYMAN TOP
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read